Clinical Research
Filter News
Found 111,234 articles
-
BioSpace Global Roundup, Oct. 17
10/17/2019
Companies from across the globe provide business and pipeline updates. -
Reenie McCarthy, chief executive officer of Stealth Biotherapeutics, has seen first-hand the negative impact of mitochondrial diseases, including watching an athlete decline from being an Olympic-level rower to becoming wheelchair-bound.
-
Growth of Point of Care (POC) Diagnostics Market to be Impacted by Rising Adoption of Automated Diagnostic Devices in Healthcare Industry | Technavio
10/17/2019
The report, global point of care diagnostics market has been added to Technavio’s catalog. It provides a comprehensive analysis of the market, including its global and regional market share as well as market segmentation based on product, end-users, and geography for the forecast period 2019-2023.
-
Arvinas to Present Initial Data from Ongoing Clinical Trials and a Pipeline Update at the 2nd Targeted Protein Degradation Summit
10/17/2019
Arvinas Inc.,, a biotechnology company creating a new class of drugs based on targeted protein degradation, announced it will be participating in multiple sessions of the 2nd Targeted Protein Degradation Summit.
-
Stallergenes Greer and Anergis Initiate New Study to Predict Efficacy of Second-Generation Allergen Immunotherapy
10/17/2019
Second-generation Allergen Immunotherapy based on Anergis Contiguous Overlapping Peptides (COP) linked to Virosomes will be tested by Stallergenes Greer using its therapeutic model of birch pollen allergy.
-
New Study Demonstrates a Unique Role of Nicotinamide Riboside Over Other NAD Precursors
10/17/2019
ChromaDex Corp. announced that the results of a preclinical study conducted by Nestlé were published last month in the journal Nature Communications, a peer-reviewed open access scientific journal published by the Nature Publishing Group.
-
Most Breast Cancers Found by Hand, Mammacare Scientists Report
10/17/2019
The team's original research was conducted at the Gainesville Florida VA Medical Center and at UF.
-
MGI Demonstrates Success of New CoolMPS™ Sequencing Chemistry on PCR-free DNBSEQ™ Platform
10/17/2019
Results from early access collaborators show high quality and reproducibility
-
INmune Bio, Inc. Announces Presentation of Data Related to its Lead Compound XPro1595 at the Society for Neuroscience’s Annual Meeting
10/17/2019
Data on Neuroinflammation and Alzheimer’s Disease to be Presented by Dr. Malú Tansey; Presentation Selected for Meeting’s Press Conference
-
Research presented by Invitae at the American Society of Human Genetics Meeting Pushes Science and Practice of Genetics Forward
10/17/2019
Researchers from Invitae Corporation (NYSE: NVTA), a leading medical genetics company, are presenting data showing the increasing utility of genetic information at the American Society of Human Genetics (ASHG) annual meeting this week, ranging from comprehensive screening for cancer patients, to appropriate clinical follow up for women using non-invasive prenatal screening, to the limitations of direct to consumer genetic screening health reports.
-
The smart choice in early-stage clinical research
10/17/2019
CATALIS Québec launches a promotional campaign to demonstrate Quebec’s expertise in the conduct of early-phase clinical trials and to encourage new partnerships between the biopharmaceutical industry and university research centres.
-
Female Forward Together, a Cross-Sector Coalition, Announced to Advance Research, Education, and Action for Women’s Health
10/17/2019
Myovant Sciences announced the formation of Female Forward Together, a cross-sector coalition bringing together expertise in healthcare, research, data science, digital health, and advocacy to improve women’s health.
-
First-of-Its-Kind Nationwide Survey from Myovant Sciences and Evidation Health Captures Impact of Menstrual Stigma & Symptoms A Majority of Women & Men Report Stigma Around Menstruation; About One in Four Women Report Heavy Menstrual Bleeding
10/17/2019
Pervasive stigma and prevalent symptoms related to menstruation are among the key takeaways from a new survey conducted by Myovant Sciences, a healthcare company focused on developing innovative treatments for women's health and prostate cancer, and Evidation Health, a health and measurement company that helps life sciences companies understand how everyday behavior and health interact.
-
ASIT biotech Mode of Action Study of gp-ASIT+™ for Grass Pollen Allergy Published in The Journal of Allergy and Clinical Immunology (JACI)¹
10/17/2019
Data show how gp-ASIT+™, administered in a pre-seasonal 3-week treatment, is able to rapidly modulate the cellular response and induce production of blocking antibodies. This effect led to a significant reduction in the combined clinical symptom and medication score during the following pollen season.
-
Versatope Therapeutics received a leg up in its universal vaccine development efforts at the end of September with a $17.9 million grant from the National institute of Allergy & Infections Diseases.
-
AI system more accurately identifies collapsed lungs using chest x-rays
10/16/2019
New assistive technology can diagnose collapsed lungs from chest x-rays with a higher degree of accuracy than radiologists.
-
Frontotemporal dementia is associated with alterations in immune system function
10/16/2019
Recent research from the University of Eastern Finland revealed increased inflammatory activity in a subgroup of patients with frontotemporal dementia Increased inflammation was associated with parkinsonism symptoms and more rapid disease progression.
-
Growth of Transcatheter Embolization and Occlusion Devices Market to be Impacted by Increasing Geriatric Population and Rising Prevalence of Chronic Diseases | Technavio
10/16/2019
The report, global transcatheter embolization and occlusion devices market has been added to Technavio’s catalog. It provides a comprehensive analysis of the market, including its global and regional market share as well as market segmentation based on product, end-users, and geography for the forecast period 2019-2023.
-
Diabetic Neuropathy Drugs Market 2019-2023 | Evolving Opportunities with Pfizer Inc. and Novartis AG | Technavio
10/16/2019
Technavio has been monitoring the global diabetic neuropathy drugs market since 2016 and the market is poised to grow by USD 866.72 million during 2019-2023, progressing at a CAGR of about 6% during the forecast period.
-
Growth of Osteoporosis Drugs Market to be Impacted by Development of Transdermal Drug Delivery System | Technavio
10/16/2019
The report, global osteoporosis drugs market has been added to Technavio’s catalog. It provides a comprehensive analysis of the market, including its global and regional market share as well as market segmentation based on product and geography for the forecast period 2019-2023.